Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 193 member A is a protein encoded by the FAM193A gene located on human chromosome 4p16.3. FAM193A acts as a positive regulator of the p53 tumor suppressor pathway largely by modulating the stability of MDM4, a key negative regulator of p53. Loss of FAM193A leads to increased MDM4 protein levels, suppression of the p53 transcriptional program, and altered cell fate after p53 pathway activation. FAM193A forms a complex with MDM2 and MDM4 in the nucleus and cytoplasm and is essential for full responsiveness to drugs targeting the p53-MDM2/4 axis, such as Nutlin. High FAM193A expression correlates with better prognosis in multiple cancers and with sensitivity to p53-activating agents. Although broadly expressed, FAM193A has also been linked to roles in neurological disease and bone development, but its full physiological functions remain incompletely understood.
Positive regulation of the p53 transcriptional network by destabilizing MDM4, thereby enhancing p53 activity; modulation of response to MDM2/4 inhibitors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 193 member A (FAM193A).